Hodgkin lymphoma is a rare B-cell malignant neoplasm affecting approximately 9000 new
patients annually. This disease represents approximately 11% of all lymphomas seen in the …

Abstract Disease Overview Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid
malignancy affecting 8500 new patients annually and representing approximately 10.2% of …

Hodgkin's disease (HD) has long been suspected to have an infectious precursor, and
indirect evidence has implicated Epstein‐Barr virus (EBV), a ubiquitous herpesvirus, as a …

Among the most common HIV-associated lymphomas are Burkitt lymphoma (BL) and diffuse
large B-cell lymphoma (DLBCL) with immunoblastic-plasmacytoid differentiation (also …

Epstein–Barr virus (EBV), a ubiquitous B-lymphotrophic herpesvirus, has been found in the
tumor cells of a heterogeneous group of malignancies (Burkitt's lymphoma, lymphomas …

Despite its well known histological and clinical features, Hodgkin's lymphoma (HL) has
recently been the object of intense research activity, leading to a better understanding of its …

Presently Hodgkin's lymphoma can be cured in at least 80% of patients. The major
challenge to the clinician in 2005 is how to cure the disease while inducing the least …

Disease overview: Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid malignancy
affecting 9,050 new patients annually and representing approximately 11.2% of all …

Despite the introduction of highly active antiretroviral therapy or combination antiretroviral
therapy (HAART and cART, respectively) patients infected with HIV might develop certain …

People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the
general population and generally have a higher mortality due to delayed diagnoses …